A $650 million deal is the latest in a growing number of CRISPR IP transactions
Last week’s licensing agreement between Mammoth and Vertex shows how deal-making in the space is gathering momentum
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.